Nemocnice Kyjov prispevkova organizace

The Anesteziologicko-resuscitační oddělení concentrates on combating severe bacterial threats. The work is carried out at Nemocnice Kyjov prispevkova organizace, testing new antimicrobial combinations and strategies to prevent infection recurrence.

• Complicated urinary tract infection (cUTI)
• Acute uncomplicated pyelonephritis (AP)
• Hospital‑acquired bacterial pneumonia (HABP)
• Ventilator‑associated bacterial pneumonia (VABP)
• Complicated intra‑abdominal infection (cIAI)

Current trials assess overall treatment success and safety of innovative IV antibiotics against carbapenem‑resistant pathogens and evaluate approaches to lower the recurrence of Clostridioides difficile infection.

In the field of respiratory health, the department investigates therapies for acute bacterial and viral lung infections that can lead to hospitalization and intensive care.

• Hospital‑acquired bacterial pneumonia (HABP)
• Ventilator‑associated bacterial pneumonia (VABP)
• Severe viral lung infections requiring supplemental oxygen

Ongoing research compares novel biologic agents with standard of care to reduce mortality and prevent progression to mechanical ventilation, while also monitoring safety and recovery speed.